fibrinogen has been researched along with Acute Yellow Atrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, JJ; Luo, XP; Ning, Q; Tao, R; Wan, XY; Wang, HW; Wang, P; Wang, XJ; Weng, XX; Wu, D; Xi, D; Xiao, F; Yan, WM | 1 |
| CONLEY, CL; HARTMANN, RC; RATNOFF, OD | 1 |
2 other study(ies) available for fibrinogen and Acute Yellow Atrophy
| Article | Year |
|---|---|
Fibrinogen-like protein 2 deficiency inhibits virus-induced fulminant hepatitis through abrogating inflammatory macrophage activation.
Topics: Animals; Fibrinogen; Hepatitis, Viral, Animal; Macrophage Activation; Massive Hepatic Necrosis; Mice; Mice, Inbred BALB C | 2022 |
Studies on afibrinogenemia. I. Afibrinogenemia in a patient with septic abortion, acute yellow atrophy of the liver and bacteremia due to E. coli.
Topics: Abortion, Septic; Afibrinogenemia; Bacteremia; Blood Coagulation; Coagulants; Escherichia coli; Female; Fibrinogen; Hemostatics; Humans; Massive Hepatic Necrosis; Pregnancy | 1951 |